Drugmaker Merck reports quarterly results Thursday morning as fears grow over the expiration of the patent on its top-selling ...

Merck & Co reports Q1 earnings on Thursday with EPS of $2.14 and revenue of $15.33B expected. Despite a 38.04% drop in stock ...

In the last two years, Merck has beaten EPS estimates 88% of the time, and revenue estimates 100% of the time. Meanwhile, ...

The 2023 decision to upend affirmative action, coupled with ongoing federal funding cuts, may threaten representation of Black leaders in the pharma industry.

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...